NeuroPace (NPCE) Equity Ratio (2020 - 2026)
NeuroPace has reported Equity Ratio over the past 7 years, most recently at 0.15 for Q1 2026.
- For Q1 2026, Equity Ratio fell 33.63% year-over-year to 0.15; the TTM value through Mar 2026 reached 0.15, down 33.63%, while the annual FY2025 figure was 0.18, 112.94% up from the prior year.
- Equity Ratio for Q1 2026 was 0.15 at NeuroPace, down from 0.18 in the prior quarter.
- Over five years, Equity Ratio peaked at 0.49 in Q1 2022 and troughed at 0.08 in Q4 2024.
- A 5-year average of 0.22 and a median of 0.18 in 2025 define the central range for Equity Ratio.
- Biggest five-year swings in Equity Ratio: soared 115.67% in 2022 and later plummeted 55.87% in 2024.
- Year by year, Equity Ratio stood at 0.3 in 2022, then plummeted by 37.05% to 0.19 in 2023, then plummeted by 55.87% to 0.08 in 2024, then soared by 112.94% to 0.18 in 2025, then decreased by 18.93% to 0.15 in 2026.
- Business Quant data shows Equity Ratio for NPCE at 0.15 in Q1 2026, 0.18 in Q4 2025, and 0.17 in Q3 2025.